1-11846903-T-C

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_006172.4(NPPA):​c.450+210A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.445 in 148,354 control chromosomes in the GnomAD database, including 15,528 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.45 ( 15528 hom., cov: 26)

Consequence

NPPA
NM_006172.4 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -2.21

Publications

4 publications found
Variant links:
Genes affected
NPPA (HGNC:7939): (natriuretic peptide A) The protein encoded by this gene belongs to the natriuretic peptide family. Natriuretic peptides are implicated in the control of extracellular fluid volume and electrolyte homeostasis. This protein is synthesized as a large precursor (containing a signal peptide), which is processed to release a peptide from the N-terminus with similarity to vasoactive peptide, cardiodilatin, and another peptide from the C-terminus with natriuretic-diuretic activity. Mutations in this gene have been associated with atrial fibrillation familial type 6. This gene is located adjacent to another member of the natriuretic family of peptides on chromosome 1. [provided by RefSeq, Oct 2015]
CLCN6 (HGNC:2024): (chloride voltage-gated channel 6) This gene encodes a member of the voltage-dependent chloride channel protein family. Members of this family can function as either chloride channels or antiporters. This protein is primarily localized to late endosomes and functions as a chloride/proton antiporter. Alternate splicing results in both coding and non-coding variants. Additional alternately spliced variants have been described but their full-length structure is unknown. [provided by RefSeq, Mar 2012]
NPPA-AS1 (HGNC:37635): (NPPA antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BP6
Variant 1-11846903-T-C is Benign according to our data. Variant chr1-11846903-T-C is described in ClinVar as Benign. ClinVar VariationId is 1181476.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.57 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006172.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NPPA
NM_006172.4
MANE Select
c.450+210A>G
intron
N/ANP_006163.1P01160
NPPA-AS1
NR_037806.1
n.1480-531T>C
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NPPA
ENST00000376480.7
TSL:1 MANE Select
c.450+210A>G
intron
N/AENSP00000365663.3P01160
CLCN6
ENST00000446542.5
TSL:1
n.782-531T>C
intron
N/A
NPPA
ENST00000376476.1
TSL:3
c.300+210A>G
intron
N/AENSP00000365659.1B0ZBE8

Frequencies

GnomAD3 genomes
AF:
0.445
AC:
66016
AN:
148276
Hom.:
15503
Cov.:
26
show subpopulations
Gnomad AFR
AF:
0.575
Gnomad AMI
AF:
0.398
Gnomad AMR
AF:
0.316
Gnomad ASJ
AF:
0.367
Gnomad EAS
AF:
0.230
Gnomad SAS
AF:
0.512
Gnomad FIN
AF:
0.375
Gnomad MID
AF:
0.516
Gnomad NFE
AF:
0.422
Gnomad OTH
AF:
0.438
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.445
AC:
66070
AN:
148354
Hom.:
15528
Cov.:
26
AF XY:
0.443
AC XY:
31872
AN XY:
71954
show subpopulations
African (AFR)
AF:
0.576
AC:
23200
AN:
40286
American (AMR)
AF:
0.315
AC:
4714
AN:
14964
Ashkenazi Jewish (ASJ)
AF:
0.367
AC:
1270
AN:
3464
East Asian (EAS)
AF:
0.230
AC:
1147
AN:
4980
South Asian (SAS)
AF:
0.513
AC:
2429
AN:
4738
European-Finnish (FIN)
AF:
0.375
AC:
3438
AN:
9164
Middle Eastern (MID)
AF:
0.503
AC:
146
AN:
290
European-Non Finnish (NFE)
AF:
0.422
AC:
28452
AN:
67482
Other (OTH)
AF:
0.439
AC:
913
AN:
2078
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.526
Heterozygous variant carriers
0
1652
3304
4957
6609
8261
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
612
1224
1836
2448
3060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.418
Hom.:
1675
Bravo
AF:
0.443
Asia WGS
AF:
0.386
AC:
1339
AN:
3474

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.47
DANN
Benign
0.69
PhyloP100
-2.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs198369; hg19: chr1-11906960; API